Expertise in
4
conditions

Feng-cai P. Zhu

87 Hunan Rd, 
Nanjing, CN 
Expertise in
4
conditions
87 Hunan Rd, 
Nanjing, CN 

Overview

Feng-cai Zhu practices practicing medicine in Nanjing, China.

Zhu is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Hand-Foot-Mouth Disease (HFMD), Severe Acute Respiratory Syndrome (SARS), Herpangina, and COVID-19.

They are actively involved in clinical research, co-authoring 115 peer reviewed articles and participating in 1 clinical trial.

Locations

87 Hunan Rd, Nanjing, 210009, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicenter, Randomized, Double-Blind, Controlled (Bivalent Human Papillomavirus Vaccine (16,18 Type)(E. Coli)) Phase III Clinical Trial to Estimate Efficacy, Immunogenicity and Safty of the Recombinant Human Papillomavirus Vaccine (6,11,16,18,31,33,45,52,58 Type) (E.Coli) in Healthy Women Aged 18 to 45 Years
A Multicenter, Randomized, Double-Blind, Controlled (Bivalent Human Papillomavirus Vaccine (16,18 Type)(E. Coli)) Phase III Clinical Trial to Estimate Efficacy, Immunogenicity and Safty of the Recombinant Human Papillomavirus Vaccine (6,11,16,18,31,33,45,52,58 Type) (E.Coli) in Healthy Women Aged 18 to 45 Years
Enrollment Status: Active_not_recruiting
Publish Date: November 21, 2025
Intervention Type: Biological
Study Drug: Gardasil9 Nonavalent Human Papillomavirus Vaccine
Study Phase: Phase 3

115 Total Publications

Adverse reaction characteristics of five COVID-19 vaccines across different technology platforms: a pooled analysis of nine clinical trials.
Adverse reaction characteristics of five COVID-19 vaccines across different technology platforms: a pooled analysis of nine clinical trials.
Journal: Expert review of vaccines
Published: May 07, 2025

Frequently Asked Questions about Feng-cai P. Zhu

Is Feng-cai P. Zhu a top-rated expert for Hand-Foot-Mouth Disease (HFMD)?

MediFind is an objective health platform that identifies experts based on real-world data. Feng-cai P. Zhu is classified as an Advanced expert for Hand-Foot-Mouth Disease (HFMD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Feng-cai P. Zhu participate in research or clinical trials?

Yes. Feng-cai P. Zhu has published 115 articles and abstracts on conditions like Hand-Foot-Mouth Disease (HFMD). You can view a list of Feng-cai P. Zhu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zhu's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile